drugset / Trial / NCT00393861
Study of Oxaliplatin Plus Bevacizumab in Germ Cell Tumor Patients
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the effectiveness of oxaliplatin and bevacizumab in patients with refractory or relapsed germ cell tumors.
Timeline
- Start
- 2006-10
- Primary completion
- 2012-10
- Completion
- 2014-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bevacizumab | Monoclonal antibody | 10 mg/kg | Intravenous |
| Subject | Oxaliplatin | Small molecule | 85 mg/m2 | Intravenous |